Trigger Point Injections in Anterior Cervical Surgery

Launched by GEORGE WASHINGTON UNIVERSITY · Nov 18, 2020

Keywords

ClinConnect Summary

**Clinical Trial Summary: Trigger Point Injections in Anterior Cervical Surgery**

This clinical trial is studying the use of trigger point injections to help reduce neck pain in patients who have undergone anterior cervical surgery, such as a procedure to relieve pressure on the spinal cord or nerves. After surgery, many patients experience stiffness and pain in the back of the neck in addition to pain at the incision site. This trial will explore whether injecting a small amount of numbing medication into specific tender spots in the neck and upper back can help ease this pain and reduce the need for stronger pain medications.

To be eligible for this trial, participants must be scheduled for elective anterior cervical surgery and be between the ages of 65 and 74. Those with allergies to local anesthetics or who have been using certain strong pain medications for a long time may not qualify. If you join the study, you can expect to receive standard post-operative care along with the trigger point injections to see if they improve your recovery experience. This trial aims to provide valuable insights into managing pain after neck surgery and potentially improve the overall quality of care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Elective anterior cervical surgery
• Exclusion Criteria:
• • Emergency surgery
• • Local anesthetic allergy
• • Long term opioid usage (not including tramadol and codeine)
• • Intra-operative complication (e.g. unstable cervical spine)